Aurubis stock: Annual report due December 2, 2026. Analysts target Aurubis stock at EUR 165.44

Published on 10/23/2026 at 15:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Operating EBT reached EUR 374.00 million, up 31.00 percent. Aurubis stock costs EUR 131.15 on October 23, 2026, down 0.27 percent versus Xetra close.

Annual report and earnings

Aurubis annual report is scheduled for December 2, 2026.
Nine-month operating EBT rose 31.00 percent to EUR 374.00 million in fiscal 2025/2026.
Aurubis stock costs EUR 131.15 at Lang & Schwarz on October 23, 2026 at 3:14 p.m. CEST, 0.27 percent below the Xetra close of October 22, 2026.
Eight analysts set an average target of EUR 165.44, while Aurubis trades within a EUR 104.80 to EUR 225.20 52-week range.

Dokumentarische Schwarzweiß-Aufnahme von Arbeitern bei der Kupferkathoden-Kontrolle — Aurubis AG dokumentarische Schwarzweiß-Reportage zeigt Arbeiter beim Prüfen von Kupferkathoden, ISIN DE0006766504, Illustration mit AI erstellt.

Aurubis is scheduled to publish its fiscal 2025/2026 annual report on December 2, 2026, according to Yahoo Finance. The company reported operating EBT of EUR 374.00 million for the first nine months of fiscal 2025/2026, up 31.00 percent from the prior-year period, while the stock was trading at EUR 131.15 at Lang & Schwarz on October 23, 2026 at 3:14 p.m. CEST, down 0.27 percent versus the Xetra close of October 22, 2026.

Nine-month earnings improved 31.00 percent

The latest operating figures give Aurubis a stronger earnings base before the annual report. Yahoo Finance reported group revenue of EUR 17,769 million for the first nine months of fiscal 2025/2026, an increase of 29.00 percent. Operating EBITDA reached EUR 570.00 million, while management confirmed full-year operating EBITDA guidance of EUR 700.00 million to EUR 800.00 million and operating EBT guidance of EUR 425.00 million to EUR 525.00 million.

What does the price position show?

The market value sits well above the 52-week low but below the annual high. Aurubis traded at EUR 131.15 on October 23, 2026, against a 52-week range of EUR 104.80 to EUR 225.20. The price was 41.76 percent below the high and 25.14 percent above the low. Market capitalization stood at EUR 5.7 billion on October 23, 2026, and the price-to-earnings ratio was 5.76.

Valuation and reporting dates

The December 2, 2026 annual report is the next scheduled corporate date identified in the earnings-call transcript. The same transcript states that the first-quarter publication is planned for February 4, 2027, followed by the annual meeting on February 11, 2027. Aurubis also said operating EBT should reach the upper end of the EUR 425.00 million to EUR 525.00 million full-year range.

The next dated checkpoint

For investors, the annual report will put the 31.00 percent nine-month operating EBT increase alongside the full-year guidance range. The share price remains below its 52-week high, while the valuation is reflected in a price-to-earnings ratio of 5.76.

The further course of trading is shown by the continuously updated real-time quote of Aurubis stock.